(Q73179031)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074181%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Efficacy and tolerability of 1000-4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074181%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

R Grant

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074181%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S D Shorvon

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074181%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074181%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074181%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074181%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074181%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

89-95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074181%20AND%20SRC:MED&resulttype=core&format=json

Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900158-3

7 January 2021

Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900158-3

7 January 2021

Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900158-3

7 January 2021

New antiepileptic drugs: a systematic review of their efficacy and tolerability

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900158-3

7 January 2021

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900158-3

7 January 2021

Pharmacokinetic profile of levetiracetam: toward ideal characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900158-3

7 January 2021

The new generation of antiepileptic drugs: advantages and disadvantages

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900158-3

7 January 2021

The clinical pharmacokinetics of the newer antiepileptic drugs. Focus on topiramate, zonisamide and tiagabine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900158-3

7 January 2021

Two antiepileptic drugs for intractable epilepsy with complex-partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900158-3

7 January 2021

Clinical pharmacokinetics of new antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900158-3

7 January 2021

10.1016/S0920-1211(00)00158-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074181%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference